Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity

被引:43
作者
Ezquer, Fernando E. [1 ]
Ezquer, Marcelo E. [1 ]
Vicencio, Jose M. [2 ]
Calligaris, Sebastian D. [1 ]
机构
[1] Clin Alemana Univ Desarrollo, Fac Med, Ctr Med Regenerat, Santiago, Chile
[2] UCL, Inst Canc, London, England
关键词
cell engraftment; cell therapy; conditioning; homing; mesenchymal stem cell; strategies; ACUTE MYOCARDIAL-INFARCTION; PLATELET-RICH PLASMA; BONE-MARROW; EFFICACY; HYPOXIA; REPAIR; SURVIVAL; MICROENVIRONMENT; DIFFERENTIATION; TRIMETAZIDINE;
D O I
10.1080/19336918.2016.1197480
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the past 2 decades, therapies based on mesenchymal stem cells (MSC) have been tested to treat several types of diseases in clinical studies, due to their potential for tissue repair and regeneration. Currently, MSC-based therapy is considered a biologically safe procedure, with the therapeutic results being very promising. However, the benefits of these therapies are not stable in the long term, and the final outcomes manifest with high inter-patient variability. The major cause of these therapeutic limitations results from the poor engraftment of the transplanted cells. Researchers have developed separate strategies to improve MSC engraftment. One strategy aims at increasing the survival of the transplanted MSCs in the recipient tissue, rendering them more resistant to the hostile microenvironment (cell-preconditioning). Another strategy aims at making the damaged tissue more receptive to the transplanted cells, favoring their interactions (tissue-preconditioning). In this review, we summarize several approaches using these strategies, providing an integral and updated view of the recent developments in MSC-based therapies. In addition, we propose that the combined use of these different conditioning strategies could accelerate the process to translate experimental evidences from pre-clinic studies to the daily clinical practice.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
[31]   Mesenchymal Stem Cell-based Therapy for Type 1 Diabetes [J].
Wu, Hao ;
Mahato, Ram I. .
DISCOVERY MEDICINE, 2014, 17 (93) :139-143
[32]   Stem Cell-Based Cell Therapy in Neurological Diseases: A Review [J].
Kim, Seung U. ;
de Vellis, Jean .
JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (10) :2183-2200
[33]   Stem cell-based strategies for skeletal muscle tissue engineering [J].
Baldwin, Christofer ;
Kim, Johntaehwan ;
Sivaraman, Srikanth ;
Rao, Raj R. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2022, 16 (12) :1061-1068
[34]   Stem cell-based cell replacement strategies for the central nervous system [J].
Sharp, Jason ;
Keirstead, Hans S. .
NEUROSCIENCE LETTERS, 2009, 456 (03) :107-111
[35]   Stem Cell-Based Cardiac Tissue Engineering [J].
Nunes, Sara S. ;
Song, Hannah ;
Chiang, C. Katherine ;
Radisic, Milica .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2011, 4 (05) :592-602
[36]   Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation [J].
Abdolmohammadi, Kamal ;
Mahmoudi, Tayebeh ;
Alimohammadi, Mina ;
Tahmasebi, Safa ;
Zavvar, Mahdi ;
Hashemi, Seyed Mahmoud .
LIFE SCIENCES, 2023, 312
[37]   Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives [J].
Liang, Xiaoting ;
Ding, Yue ;
Zhang, Yuelin ;
Tse, Hung-Fat ;
Lian, Qizhou .
CELL TRANSPLANTATION, 2014, 23 (09) :1045-1059
[38]   Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies [J].
Nadia de Cassia Noronha, N. C. ;
Mizukami, Amanda ;
Caliari-Oliveira, Carolina ;
Cominal, Jucara Gastaldi ;
Rocha, Jose Lucas M. ;
Covas, Dimas Tadeu ;
Swiech, Kamilla ;
Malmegrim, Kelen C. R. .
STEM CELL RESEARCH & THERAPY, 2019, 10 (1)
[39]   The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy [J].
Zhang, Jun ;
Huang, Xiaowen ;
Wang, Haijun ;
Liu, Xiaoyan ;
Zhang, Tao ;
Wang, Yunchuan ;
Hu, Dahai .
STEM CELL RESEARCH & THERAPY, 2015, 6
[40]   Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer [J].
Svajger, Urban ;
Kamensek, Urska .
CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 77 :76-90